Ascendiant Capital Markets Cuts Alzamend Neuro (NASDAQ:ALZN) Price Target to $32.00
Alzamend Neuro (NASDAQ:ALZN – Free Report) had its price target lowered by Ascendiant Capital Markets from $35.00 to $32.00 in a research note issued to investors on Monday morning,Benzinga reports. The firm currently has a buy rating on the stock. Alzamend Neuro Stock Performance NASDAQ:ALZN opened at $1.23 on Monday. The stock’s 50 day moving […]
More Stories
iTeos Therapeutics (NASDAQ:ITOS) Price Target Lowered to $19.00 at Wells Fargo & Company
iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) had its target price decreased by analysts at Wells Fargo & Company from...
Morgan Stanley Issues Positive Forecast for Block (NYSE:SQ) Stock Price
Block (NYSE:SQ – Free Report) had its target price raised by Morgan Stanley from $60.00 to $65.00 in a research...
Tronox Holdings PLC Enters into Term Loan Repricing Agreement
Tronox Holdings PLC, a global mining and inorganic chemicals company, announced on December 18, 2024, that its subsidiary, Tronox Finance...
Zacks Research Predicts Stronger Earnings for Curtiss-Wright
Curtiss-Wright Co. (NYSE:CW – Free Report) – Stock analysts at Zacks Research upped their FY2024 EPS estimates for Curtiss-Wright in...
**Edible Garden Reports 51% Surge in Thanksgiving Sales****
** Edible Garden AG Incorporated (NASDAQ: EDBL) has recently disclosed its preliminary financial performance for the Thanksgiving holiday period, showcasing...
FY2024 EPS Estimates for OTCMKTS:MHGU Cut by Northland Capmk
Meritage Hospitality Group Inc. (OTCMKTS:MHGU – Free Report) – Northland Capmk decreased their FY2024 earnings per share (EPS) estimates for...